Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Follicular Lymphoma Targeted Therapy

Jonathon Cohen

MD, MS

🏢Emory University Winship Cancer Institute🌐USA

Associate Professor of Medicine

32
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jonathon Cohen is a lymphoma specialist with expertise in PI3K inhibitor development for follicular lymphoma. His clinical research has evaluated copanlisib, duvelisib, and next-generation PI3K inhibitors, characterizing their efficacy and immune-mediated toxicity profiles. He has contributed to strategies for managing PI3K inhibitor-associated colitis and pneumonitis.

Share:

🧪Research Fields 研究领域

PI3K inhibitors FL
Copanlisib
Duvelisib
Immune toxicity PI3K
Novel combinations FL

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jonathon Cohen 的研究动态

Follow Jonathon Cohen's research updates

留下邮箱,当我们发布与 Jonathon Cohen(Emory University Winship Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment